Suchergebnisse - "Julkunen, Heikki"

PubPharm (69)

1

Early Targeted Combination Treatment With Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Long-Term Outcomes in Rheumatoid Arthritis : Ten-Year Follow-Up Results of a Randomized Clinical Trial

enthalten in: Arthritis care & research | 2019

von Rantalaiho, V. | Sandström, T. | Koski, J. | +12

2

European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block

enthalten in: Annals of the rheumatic diseases | 2018

von Kyriakidis, N. | Kockum, I. | Julkunen, H. | +13

3

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

enthalten in: Clinical rheumatology | 2018

von Kuusalo, L. | Puolakka, K. | Kautiainen, H. | +32

4

Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis : a post hoc analysis from the NEO-RACo trial

enthalten in: Clinical and experimental rheumatology | 2016

von Kuusalo, L. | Puolakka, K. | Kautiainen, H. | +12

5

Successful Treatment of Intermittent Hydrarthrosis With Hydroxychloroquine

enthalten in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | 2015

von Julkunen, H.

6

Successful Treatment of Intermittent Hydrarthrosis With Hydroxychloroquine

enthalten in: Journal of clinical rheumatology | 2015

von Julkunen, H.

7

Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months : the 5-year followup results of the randomized clinical NEO-RACo trial

enthalten in: The Journal of rheumatology | 2014

von Rantalaiho, V. | Kautiainen, H. | Järvenpää, S. | +40

8

Failure in Longterm Treatment is Rare in Actively Treated Patients with Rheumatoid Arthritis, But May Be Predicted by High Health Assessment Score at Baseline and by Residual Disease Activity at 3 and 6 Months: The 5-year Followup Results of the Randomized Clinical NEO-RACo Trial

enthalten in: Journal of rheumatology | 2014

von Rantalaiho, V. | Kautiainen, H. | Jrvenp, S. | +33

9

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

enthalten in: Annals of the rheumatic diseases | 2014

von Rantalaiho, V. | Kautiainen, H. | Korpela, M. | +37

10

Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus

enthalten in: Rheumatology international | 2014

von Ekblom-Kullberg, S. | Kautiainen, H. | Alha, P. | +3

1
2
3
4
5
6
7
Nächster »
[7]